annual SGA:
$0.00-$247.37M(-100.00%)Summary
- As of today (August 20, 2025), GSK annual SGA is $0.00, with the most recent change of -$247.37 million (-100.00%) on December 31, 2024.
- During the last 3 years, GSK annual SGA has fallen by -$232.43 million (-100.00%).
- GSK annual SGA is now -100.00% below its all-time high of $20.15 billion, reached on December 31, 2010.
Performance
GSK SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$2.61B(-100.00%)Summary
- As of today (August 20, 2025), GSK quarterly SGA is $0.00, with the most recent change of -$2.61 billion (-100.00%) on June 30, 2025.
- Over the past year, GSK quarterly SGA has dropped by -$3.11 billion (-100.00%).
- GSK quarterly SGA is now -100.00% below its all-time high of $7.02 billion, reached on December 31, 2010.
Performance
GSK quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$43.55B+$1.21B(+2.86%)Summary
- As of today (August 20, 2025), GSK TTM SGA is $43.55 billion, with the most recent change of +$1.21 billion (+2.86%) on June 30, 2025.
- Over the past year, GSK TTM SGA has increased by +$31.57 billion (+263.42%).
- GSK TTM SGA is now -24.19% below its all-time high of $57.45 billion.
Performance
GSK TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
GSK Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -100.0% | +263.4% |
| 3 y3 years | -100.0% | -100.0% | +323.2% |
| 5 y5 years | -100.0% | -100.0% | +188.8% |
GSK Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low | -4.8% | +87.1% |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low | -4.8% | +87.1% |
| alltime | all time | -100.0% | at low | -100.0% | at low | -24.2% | +234.2% |
GSK Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $7.55B(-29.2%) |
| Mar 2025 | - | $2.61B(>+9900.0%) | $10.66B(-0.4%) |
| Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $10.70B(-23.7%) |
| Sep 2024 | - | $4.94B(+58.8%) | $14.02B(+17.0%) |
| Jun 2024 | - | $3.11B(+17.5%) | $11.98B(+2.3%) |
| Mar 2024 | - | $2.65B(-20.4%) | $11.71B(+0.4%) |
| Dec 2023 | $247.37M(+4.6%) | $3.32B(+14.3%) | $11.67B(+4.1%) |
| Sep 2023 | - | $2.91B(+2.3%) | $11.21B(+4.6%) |
| Jun 2023 | - | $2.84B(+9.0%) | $10.72B(+2.4%) |
| Mar 2023 | - | $2.60B(-8.9%) | $10.47B(+1.7%) |
| Dec 2022 | $236.50M(+1.8%) | $2.86B(+18.3%) | $10.30B(-0.9%) |
| Sep 2022 | - | $2.42B(-6.7%) | $10.39B(+1.0%) |
| Jun 2022 | - | $2.59B(+6.6%) | $10.29B(+2.3%) |
| Mar 2022 | - | $2.43B(-17.8%) | $10.06B(-8.4%) |
| Dec 2021 | $232.43M(-55.6%) | $2.96B(+27.8%) | $10.98B(-10.0%) |
| Sep 2021 | - | $2.31B(-2.1%) | $12.20B(-8.5%) |
| Jun 2021 | - | $2.36B(-29.4%) | $13.33B(-7.0%) |
| Mar 2021 | - | $3.35B(-19.8%) | $14.33B(-2.6%) |
| Dec 2020 | $523.20M(+4.4%) | $4.18B(+21.1%) | $14.71B(-1.7%) |
| Sep 2020 | - | $3.45B(+2.5%) | $14.97B(-0.8%) |
| Jun 2020 | - | $3.36B(-9.7%) | $15.08B(+0.2%) |
| Mar 2020 | - | $3.73B(-15.9%) | $15.05B(+3.4%) |
| Dec 2019 | $501.37M(-96.2%) | $4.43B(+24.3%) | $14.55B(+7.9%) |
| Sep 2019 | - | $3.56B(+7.1%) | $13.49B(+2.1%) |
| Jun 2019 | - | $3.33B(+3.2%) | $13.22B(-0.1%) |
| Mar 2019 | - | $3.23B(-4.3%) | $13.23B(+0.1%) |
| Dec 2018 | $13.22B(+6.1%) | $3.37B(+2.3%) | $13.22B(+0.1%) |
| Sep 2018 | - | $3.29B(-1.4%) | $13.21B(+2.1%) |
| Jun 2018 | - | $3.34B(+3.9%) | $12.94B(+2.3%) |
| Mar 2018 | - | $3.22B(-4.3%) | $12.64B(+1.4%) |
| Dec 2017 | $12.46B(-1.2%) | $3.36B(+11.3%) | $12.46B(+0.1%) |
| Sep 2017 | - | $3.02B(-0.9%) | $12.45B(+0.1%) |
| Jun 2017 | - | $3.05B(+0.2%) | $12.44B(-0.3%) |
| Mar 2017 | - | $3.04B(-9.3%) | $12.48B(-0.5%) |
| Dec 2016 | $12.60B(-10.6%) | $3.35B(+11.4%) | $12.54B(-3.4%) |
| Sep 2016 | - | $3.01B(-2.5%) | $12.98B(-0.1%) |
| Jun 2016 | - | $3.09B(-0.5%) | $13.00B(-6.1%) |
| Mar 2016 | - | $3.10B(-18.2%) | $13.84B(-1.8%) |
| Dec 2015 | $14.10B(+3.9%) | $3.79B(+25.2%) | $14.10B(+2.1%) |
| Sep 2015 | - | $3.03B(-22.9%) | $13.81B(-2.2%) |
| Jun 2015 | - | $3.93B(+16.8%) | $14.12B(+3.3%) |
| Mar 2015 | - | $3.36B(-3.8%) | $13.67B(+0.6%) |
| Dec 2014 | $13.58B(+10.5%) | $3.49B(+4.8%) | $13.58B(+7.4%) |
| Sep 2014 | - | $3.33B(-4.1%) | $12.64B(+2.1%) |
| Jun 2014 | - | $3.48B(+6.1%) | $12.38B(+0.6%) |
| Mar 2014 | - | $3.28B(+28.2%) | $12.31B(+0.4%) |
| Dec 2013 | $12.29B(-11.5%) | $2.55B(-16.9%) | $12.26B(-7.3%) |
| Sep 2013 | - | $3.07B(-9.6%) | $13.23B(-3.3%) |
| Jun 2013 | - | $3.40B(+5.5%) | $13.68B(-0.6%) |
| Mar 2013 | - | $3.23B(-8.4%) | $13.76B(-1.0%) |
| Dec 2012 | $13.88B(+4.3%) | $3.52B(-0.2%) | $13.90B(+5.8%) |
| Sep 2012 | - | $3.53B(+1.5%) | $13.13B(+2.3%) |
| Jun 2012 | - | $3.48B(+3.4%) | $12.84B(-2.6%) |
| Mar 2012 | - | $3.37B(+22.1%) | $13.18B(-0.7%) |
| Dec 2011 | $13.32B(-33.9%) | $2.76B(-14.9%) | $13.27B(-24.3%) |
| Sep 2011 | - | $3.24B(-15.3%) | $17.54B(+0.3%) |
| Jun 2011 | - | $3.82B(+10.6%) | $17.48B(-12.3%) |
| Mar 2011 | - | $3.46B(-50.8%) | $19.93B(-0.9%) |
| Dec 2010 | $20.15B | $7.02B(+120.7%) | $20.11B(+12.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $3.18B(-49.3%) | $17.92B(-1.9%) |
| Jun 2010 | - | $6.27B(+72.6%) | $18.26B(+18.3%) |
| Mar 2010 | - | $3.64B(-24.7%) | $15.44B(+3.2%) |
| Dec 2009 | $15.05B(+6.8%) | $4.83B(+37.2%) | $14.96B(+9.7%) |
| Sep 2009 | - | $3.52B(+1.9%) | $13.64B(+1.0%) |
| Jun 2009 | - | $3.45B(+9.5%) | $13.51B(-0.8%) |
| Mar 2009 | - | $3.15B(-10.2%) | $13.61B(-2.3%) |
| Dec 2008 | $14.09B(+1.3%) | $3.51B(+3.6%) | $13.93B(+0.5%) |
| Sep 2008 | - | $3.39B(-4.8%) | $13.86B(+0.9%) |
| Jun 2008 | - | $3.56B(+2.6%) | $13.74B(-0.7%) |
| Mar 2008 | - | $3.47B(+0.7%) | $13.84B(+1.5%) |
| Dec 2007 | $13.92B(+4.2%) | $3.45B(+5.5%) | $13.64B(+33.8%) |
| Sep 2007 | - | $3.27B(-10.6%) | $10.19B(+47.2%) |
| Jun 2007 | - | $3.66B(+11.9%) | $6.93B(+111.9%) |
| Mar 2007 | - | $3.27B(>+9900.0%) | $3.27B(>+9900.0%) |
| Dec 2006 | $13.36B(+1.4%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2005 | $13.17B(-0.1%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2004 | $13.19B(+6.5%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2003 | $12.38B(>+9900.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2001 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2001 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2001 | - | $0.00(0.0%) | $2.56B(-52.0%) |
| Mar 2001 | - | $0.00(-100.0%) | $5.33B(-32.0%) |
| Dec 2000 | $0.00(0.0%) | - | - |
| Sep 2000 | - | $2.56B(-7.7%) | $7.83B(+48.5%) |
| Jun 2000 | - | $2.77B(+10.6%) | $5.27B(+44.1%) |
| Mar 2000 | - | $2.50B(+117.0%) | $3.66B(+217.0%) |
| Dec 1999 | $0.00(-100.0%) | - | - |
| Jun 1999 | - | $1.15B(+5.2%) | $1.15B(+5.2%) |
| Dec 1998 | $4.45B(+3.2%) | - | - |
| Jun 1998 | - | $1.10B | $1.10B |
| Dec 1997 | $4.32B(+5.0%) | - | - |
| Dec 1996 | $4.11B(-1.8%) | - | - |
| Dec 1995 | $4.19B(+40.7%) | - | - |
| Jun 1994 | $2.98B(>+9900.0%) | - | - |
| Jun 1993 | $0.00(0.0%) | - | - |
| Jun 1992 | $0.00(0.0%) | - | - |
| Jun 1991 | $0.00(-100.0%) | - | - |
| Jun 1990 | $63.47M(+42.2%) | - | - |
| Jun 1989 | $44.62M(+154.5%) | - | - |
| Jun 1988 | $17.54M(+91.6%) | - | - |
| Jun 1987 | $9.15M(+27.1%) | - | - |
| Jun 1986 | $7.20M | - | - |
FAQ
- What is GSK plc annual SGA?
- What is the all time high annual SGA for GSK plc?
- What is GSK plc annual SGA year-on-year change?
- What is GSK plc quarterly SGA?
- What is the all time high quarterly SGA for GSK plc?
- What is GSK plc quarterly SGA year-on-year change?
- What is GSK plc TTM SGA?
- What is the all time high TTM SGA for GSK plc?
- What is GSK plc TTM SGA year-on-year change?
What is GSK plc annual SGA?
The current annual SGA of GSK is $0.00
What is the all time high annual SGA for GSK plc?
GSK plc all-time high annual SGA is $20.15B
What is GSK plc annual SGA year-on-year change?
Over the past year, GSK annual SGA has changed by -$247.37M (-100.00%)
What is GSK plc quarterly SGA?
The current quarterly SGA of GSK is $0.00
What is the all time high quarterly SGA for GSK plc?
GSK plc all-time high quarterly SGA is $7.02B
What is GSK plc quarterly SGA year-on-year change?
Over the past year, GSK quarterly SGA has changed by -$3.11B (-100.00%)
What is GSK plc TTM SGA?
The current TTM SGA of GSK is $43.55B
What is the all time high TTM SGA for GSK plc?
GSK plc all-time high TTM SGA is $57.45B
What is GSK plc TTM SGA year-on-year change?
Over the past year, GSK TTM SGA has changed by +$31.57B (+263.42%)